SF3A3 and colorectal carcinoma: Last but not least, both functional experiments and drug sensitivity test were carried out in this study, helping explore the biological mechanisms of SF3A3 underlying CRC development and provide a theoretical basis for future clinical application of PEITC targeting SF3A3 in CRC treatment.